Misonix, Inc. MSON
Set alert
As of Apr 24, 3:47 PM ET
52-week range unavailable
- Open
- 25.38
- Prev close
- 26.54
- Mkt cap
- 462.46M
- Vol
- 157.17K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 25.08
- High
- 26.56
- Forward P/E
- -42.81
- Beta
- 1.35
- Short ratio
- 3.26
- Inst. own
- 40.97%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Sep 2, 2021
- 50-d avg
- 25.71
- 200-d avg
- 23.51
- 1y target
- 28.00
Key statistics
- Market cap
- 462.46M
- Enterprise value
- 478.22M
- Trailing P/E
- 0.00
- Forward P/E
- -42.81
- PEG ratio
- -0.93
- Price / sales
- 6.25
- Price / book
- 3.42
- EPS (TTM)
- -0.84
- Beta
- 1.35
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -19.55%
- Revenue (TTM)
- 74.02M
- Revenue growth
- 43.50%
- Free cash flow
- 1.54M
- Total cash
- 31.05M
- Total debt
- 47.20M
- Return on equity
- -10.27%
- Shares outstanding
- 17.43M
- Short % of float
- 1.33%
- 50-day average
- 25.71
- 200-day average
- 23.51
Analyst view
Consensus: hold
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Sep 2, 2021
Expected Sep 2, 2021. Consensus EPS estimate -0.28.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Sep 2, 2021 | Jun 1, 2021 | 0.00 | — | — | — |
| May 6, 2021 | Mar 1, 2021 | 0.00 | — | — | — |
| Feb 4, 2021 | Dec 1, 2020 | 0.00 | — | — | — |
| Nov 5, 2020 | Sep 1, 2020 | 0.00 | — | — | — |
| Sep 3, 2020 | Jun 1, 2020 | 0.00 | — | — | — |
| May 11, 2020 | Mar 1, 2020 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 2, 2021 | BTIG | down | Buy | Neutral |
| Jul 30, 2021 | Craig-Hallum | down | Buy | Hold |
| Jul 30, 2021 | Canaccord Genuity | down | Buy | Hold |
| May 15, 2020 | Canaccord Genuity | main | — | Buy |
| Apr 3, 2020 | BTIG | main | — | Buy |
| Jun 12, 2019 | BTIG Research | init | — | Buy |
About Misonix, Inc.
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator, which is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system that provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York. As of October 29, 2021, Misonix, Inc. operates as a subsidiary of Bioventus Inc.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- misonix.com
News
- SHAREHOLDER ALERT: WeissLaw LLP Reminds KRA, HOMB, MSON, and VNE Shareholders About Its Ongoing Investigations
- SHAREHOLDER ALERT: Halper Sadeh LLP Investigates HBMD, ACBI, SBKK, MSON; Shareholders are Encouraged to Contact the Firm
- Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results
- MISONIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Misonix, Inc. - MSON
- SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Misonix, Inc. - MSON
- SHAREHOLDER ALERT: WeissLaw LLP Investigates Misonix, Inc.
- Stocks That Hit 52-Week Highs On Friday
- Bioventus Scoops Up Misonix In $518M Stock & Cash Deal; Raises FY21 Sales Outlook
- Misonix Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Misonix, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – MSON
- Stocks That Hit 52-Week Highs On Monday
Your note
Sign in to keep a note on MSON — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BRENNAN JOSEPH J | Officer | Sale | Feb 10, 2019 | 5,292 |
| DWYER JOSEPH P | Chief Financial Officer | Purchase | Mar 8, 2020 | 4,700 |
| KLUGEWICZ SHARON W | Chief Operating Officer | Purchase | May 19, 2020 | 1,415 |
| LUDECKER ROBERT S | Officer | Conversion of Exercise of derivative security | Aug 26, 2018 | 11,500 |
| MCBRAYER PATRICK A | Director | Purchase | Feb 11, 2018 | 1,100 |
| MINER CHARLESIII | Director | Conversion of Exercise of derivative security | Jun 25, 2018 | 29,382 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sv Health Investors, LLC | 9.73% | 1,694,017 | 37.57M | Jun 29, 2021 |
| Blackrock Inc. | 4.76% | 829,038 | 18.39M | Jun 29, 2021 |
| Royce & Associates LP | 4.42% | 769,056 | 17.06M | Jun 29, 2021 |
| Vanguard Group, Inc. (The) | 3.59% | 624,854 | 13.86M | Jun 29, 2021 |
| Pura Vida Investments, LLC | 2.71% | 472,216 | 10.47M | Jun 29, 2021 |
| Juniper Investment Company, LLC | 2.68% | 465,920 | 10.33M | Jun 29, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.09% | 363,393 | 8.06M | Jun 29, 2021 |
| iShares Russell 2000 ETF | 1.58% | 275,407 | 6.97M | Sep 29, 2021 |
| Pennsylvania Mutual Fund Inc | 1.16% | 201,200 | 4.46M | Jun 29, 2021 |
| Vanguard Extended Market Index Fund | 1.04% | 180,234 | 4.00M | Jun 29, 2021 |
| Royce Micro-Cap Fund | 0.90% | 157,200 | 3.49M | Jun 29, 2021 |
| Royce Opportunity Fund | 0.72% | 125,556 | 2.78M | Jun 29, 2021 |